Arrowstreet Capital’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,388
| Closed | -$148K | – | 2603 |
|
|
2020
Q3 | $148K | Sell |
2,388
-2,480
| -51% | -$154K | ﹤0.01% | 2231 |
|
|
2020
Q2 | $429K | Buy |
+4,868
| New | +$429K | ﹤0.01% | 2006 |
|
|
2020
Q1 | – | Sell |
-1,198
| Closed | -$293K | – | 2190 |
|
|
2019
Q4 | $293K | Buy |
+1,198
| New | +$293K | ﹤0.01% | 1577 |
|
|
2019
Q2 | – | Sell |
-179
| Closed | -$286K | – | 1794 |
|
|
2019
Q1 | $286K | Sell |
179
-38
| -18% | -$60.7K | ﹤0.01% | 1586 |
|
|
2018
Q4 | $405K | Buy |
217
+86
| +66% | +$161K | ﹤0.01% | 1141 |
|
|
2018
Q3 | $310K | Sell |
131
-94
| -42% | -$222K | ﹤0.01% | 974 |
|
|
2018
Q2 | $775K | Buy |
+225
| New | +$775K | ﹤0.01% | 853 |
|
|
2016
Q4 | – | Sell |
-262
| Closed | -$656K | – | 2644 |
|
|
2016
Q3 | $656K | Buy |
+262
| New | +$656K | ﹤0.01% | 1175 |
|
|
2016
Q2 | – | Sell |
-413
| Closed | -$1.31M | – | 1554 |
|
|
2016
Q1 | $1.31M | Sell |
413
-10
| -2% | -$31.7K | 0.01% | 908 |
|
|
2015
Q4 | $2.17M | Buy |
+423
| New | +$2.17M | 0.01% | 781 |
|
|
2015
Q2 | – | Sell |
-1,054
| Closed | -$4.21M | – | 1324 |
|
|
2015
Q1 | $4.21M | Buy |
1,054
+785
| +292% | +$3.13M | 0.03% | 449 |
|
|
2014
Q4 | $1.32M | Buy |
+269
| New | +$1.32M | 0.01% | 827 |
|
|
2014
Q1 | – | Sell |
-857
| Closed | -$3M | – | 1394 |
|
|
2013
Q4 | $3M | Buy |
+857
| New | +$3M | 0.02% | 565 |
|